[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pen Needles Market, 2012 to 2023

January 2018 | 196 pages | ID: PB76BCCF86EEN
Precision Business Insights (PBI)

US$ 4,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Pen Needles Market

Pen needles are used in conjunction with injection pens in order to deliver injectable medications into the body. Pen needle comprises a needle which is hallowed and embedded in a plastic hub and attached to injection pens. Pen needles will available in different lengths and diameters to make them easily used by the healthcare professionals and patients to administer medications. Generally, these pen needles are used by the people with diabetes and who require insulin injections. Pen needles are an alternative delivery system of drug administration to the conventional method.

Increasing prevalence rate of diabetes is one of the primary factors that enables drive the Global Pen Needles Market. As per International Diabetes Federation (IDF), around 642 Mn of the total population is estimated to have diabetes by 2040. People with obesity are highly prone to diabetes which in turns rise market growth of pen needles. As per, Diabetes.Co.UK, obesity is reported for 80-85% of the risk of diabetes development. Growing adaptation of pen needles and minimally invasive methods over conventional systems, increasing geriatric population is expected to fuel the market growth of pen needles. However, a dearth of specialized endocrinologists to treat diabetes, hormonal imbalances, thyroid disorders etc., issues and risks related to the safe usage of pen needles and strict regulatory framework for the development of new products are the few factors which are restraining the pen needles market size growth.

The Global pen needles market is classified on the basis of type, length of the needle, therapy, end user, and geography.

Based on type, the global pen needles market is segmented into the following

Standard pen needles
Safety Pen Needles

Based on needle length, the Global pen needles market is segmented into the following

4mm
5mm
6mm
8mm
10mm
12mm

Based on therapy, the global pen needles market is segmented into the following

GLP-1
Growth Hormones
Insulin

Based on end user, the global Pen Needles Market is segmented into the following

Hospitals
Homecare
Diagnostic centers

Increasing government initiatives in the prevention of diabetes are expected to boost the market growth. For instance, in 2013, World Health Assembly introduced a comprehensive global framework which is accompanied by WHO global action plan for prevention and control of NCD 2013-2020. Growing advanced technologies is also anticipated to drive the market growth of pen needles. For example, In 2013, Becton, Dickson, and Company have launched BD Ultrafine nano 4mm pen needles with easy flow technology which enables easy adherence to insulin therapy regimens in diabetic patients.

Geographically Global Pen Needles Market is segmented into North America, Europe, Asia- Pacific, Latin America, The Middle East & Africa. North America holds the largest share in pen needles market owing to the high prevalence of diabetes, high acceptance of state-of-art technologies. As per, American Diabetes Association, in 2015, diabetes is the 7th leading cause of death in U.S with 79,535 deaths. Europe accounted for the significant share in pen needles market. Asia Pacific region is anticipated to show significant growth due to the innovative product launches, affordability, raising awareness regarding healthcare in countries like China, India, and Japan.

The major companies in the market include Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Ypsomed Holding AG (Switzerland), Terumo Corporation (Japan), HTL-STREFA S.A. (Poland), Artsana S.p.a (Italy), Allison Medical, Inc. (U.S.), UltiMed, Inc. (U.S.), ARKRAY Inc. (U.S) and Owen Mumford Ltd. (U.K.).

July 25, 2016, ARKRAY launched TechLITE Pen Needles used for subcutaneous injection of insulin for insulin-dependent diabetic patients.

29, 2014, Novo Nordisk, launched Novofine Plus, thinnest and shortest pen needle in U.S.
1. EXECUTIVE SUMMARY

2. GLOBAL PEN NEEDLES MARKET INTRODUCTION

2.1. Global Pen Needles Market – Taxonomy
2.2. Global Pen Needles Market –Definitions
  2.2.1. Type
  2.2.2. Length
  2.2.3. Therapy
  2.2.4. End-User

3. GLOBAL PEN NEEDLES MARKET DYNAMICS

3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Pen Needles Market Dynamics – Factors Impact Analysis
3.6. Global Pen Needles Market – Regulations
  3.6.1. U.S.
  3.6.2. Europe

4. GLOBAL PEN NEEDLES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 – 2023

4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Oppurtunity Analysis

5. GLOBAL PEN NEEDLES MARKET , BY TYPE, 2012 - 2016 AND FORECAST, 2017 - 2023

5.1. Standard pen needles
  5.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.1.3. Market Opportunity Analysis
5.2. Safety Pen Needles
  5.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  5.2.3. Market Opportunity Analysis

6. GLOBAL PEN NEEDLES MARKET FORECAST, BY NEEDLE LENGTH, 2012 - 2016 AND FORECAST, 2017 - 2023

6.1. 4mm
  6.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.1.3. Market Opportunity Analysis
6.2. 5mm
  6.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.2.3. Market Opportunity Analysis
6.3. 6mm
  6.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.3.3. Market Opportunity Analysis
6.4. 8mm
  6.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.4.3. Market Opportunity Analysis
6.5. 10mm
  6.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.5.3. Market Opportunity Analysis
6.6. 12mm
  6.6.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  6.6.3. Market Opportunity Analysis

7. GLOBAL PEN NEEDLES MARKET FORECAST, BY THERAPY, 2012 - 2016 AND FORECAST, 2017 - 2023

7.1. GLP-1
  7.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.1.3. Market Opportunity Analysis
7.2. Growth Hormones
  7.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.2.3. Market Opportunity Analysis
7.3. Insulin
  7.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  7.3.3. Market Opportunity Analysis

8. GLOBAL PEN NEEDLES MARKET FORECAST, BY END-USER, 2012 - 2016 AND FORECAST, 2017 - 2023

8.1. Hospitals
  8.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.1.3. Market Opportunity Analysis
8.2. Diagnostic Centres
  8.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.2.3. Market Opportunity Analysis
8.3. Homecare
  8.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  8.3.3. Market Opportunity Analysis

9. GLOBAL PEN NEEDLES MARKET FORECAST, BY REGION, 2012 - 2016 AND FORECAST, 2017 - 2023

9.1. North America
  9.1.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.1.3. Market Opportunity Analysis
9.2. Europe
  9.2.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
  9.3.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.3.3. Market Opportunity Analysis
9.4. Latin America
  9.4.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
  9.5.1. Market Analysis, 2012 – 2016 and Forecast, 2017 – 2023 (Revenue, USD Mn)
  9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  9.5.3. Market Opportunity Analysis
9.6. Global Pen Needles Market - Opportunity Analysis Index, By Type, By Needle Length, By Therapy, By End-User, and Region, 2017 – 2023

10. NORTH AMERICA PEN NEEDLES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

10.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  10.1.1. Standard pen needles
  10.1.2. Safety Pen Needles
10.2. Needle Length Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.2.1. 4mm
  10.2.2. 5mm
  10.2.3. 6mm
  10.2.4. 8mm
  10.2.5. 10mm
  10.2.6. 12mm
10.3. Therapy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.3.1. GLP-1
  10.3.2. Growth Hormones
  10.3.3. Insulin
10.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  10.4.1. Hospitals
  10.4.2. Diagnostic Centres
  10.4.3. Homecare
10.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
  10.5.1. U.S.
  10.5.2. Canada
10.6. North America Pen Needles Market - Opportunity Analysis Index, By Type, By Needle Length, By Therapy, By End-User, and Country, 2017 – 2023
10.7. North America Pen Needles Market Dynamics – Trends

11. EUROPE PEN NEEDLES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

11.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  11.1.1. Standard pen needles
  11.1.2. Safety Pen Needles
11.2. Needle Length Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.2.1. 4mm
  11.2.2. 5mm
  11.2.3. 6mm
  11.2.4. 8mm
  11.2.5. 10mm
  11.2.6. 12mm
11.3. Therapy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.3.1. GLP-1
  11.3.2. Growth Hormones
  11.3.3. Insulin
11.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.4.1. Hospitals
  11.4.2. Diagnostic Centres
  11.4.3. Homecare
11.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  11.5.1. Germany
  11.5.2. UK
  11.5.3. France
  11.5.4. Spain
  11.5.5. Italy
  11.5.6. Russia
  11.5.7. Poland
  11.5.8. Rest of Europe
11.6. Europe Pen Needles Market - Opportunity Analysis Index, By Type, By Needle Length, By Therapy, By End-User, and Country, 2017 – 2023
11.7. Europe Pen Needles Market Dynamics – Trends

12. ASIA-PACIFIC PEN NEEDLES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

12.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  12.1.1. Standard pen needles
  12.1.2. Safety Pen Needles
12.2. Needle Length Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.2.1. 4mm
  12.2.2. 5mm
  12.2.3. 6mm
  12.2.4. 8mm
  12.2.5. 10mm
  12.2.6. 12mm
12.3. Therapy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.3.1. GLP-1
  12.3.2. Growth Hormones
  12.3.3. Insulin
12.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  12.4.1. Hospitals
  12.4.2. Diagnostic Centres
  12.4.3. Homecare
12.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn),
Y-o-Y Growth (%), and Market Share (%)
  12.5.1. Japan
  12.5.2. China
  12.5.3. India
  12.5.4. ASEAN
  12.5.5. Australia & New Zealand
  12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Pen Needles Market - Opportunity Analysis Index, By Type, By Needle Length, By Therapy, By End-User, and Country, 2017 – 2023
12.7. Europe Pen Needles Market Dynamics – Trends

13. LATIN AMERICA PEN NEEDLES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

13.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  13.1.1. Standard pen needles
  13.1.2. Safety Pen Needles
13.2. Needle Length Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.2.1. 4mm
  13.2.2. 5mm
  13.2.3. 6mm
  13.2.4. 8mm
  13.2.5. 10mm
  13.2.6. 12mm
13.3. Therapy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.3.1. GLP-1
  13.3.2. Growth Hormones
  13.3.3. Insulin
13.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.4.1. Hospitals
  13.4.2. Diagnostic Centres
  13.4.3. Homecare
13.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  13.5.1. Brazil
  13.5.2. Mexico
  13.5.3. Argentina
  13.5.4. Venezuela
  13.5.5. Rest of Latin America
13.6. Latin America Pen Needles Market - Opportunity Analysis Index, By Type, By Needle Length, By Therapy, By End-User, and Country, 2017 – 2023
13.7. Latin America Pen Needles Market Dynamics – Trends

14. MIDDLE EAST AND AFRICA PEN NEEDLES MARKET ANALYSIS, 2012 - 2016 AND FORECAST, 2017 - 2023

14.1. Type Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  14.1.1. Standard pen needles
  14.1.2. Safety Pen Needles
14.2. Needle Length Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  14.2.1. 4mm
  14.2.2. 5mm
  14.2.3. 6mm
  14.2.4. 8mm
  14.2.5. 10mm
  14.2.6. 12mm
14.3. Therapy Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  14.3.1. GLP-1
  14.3.2. Growth Hormones
  14.3.3. Insulin
14.4. End-User Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
  14.4.1. Hospitals
  14.4.2. Diagnostic Centres
  14.4.3. Homecare
14.5. Country Analysis (2012 – 2016) and Forecast (2017 – 2023) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
  14.5.1. Gulf Cooperation Council (GCC) Countries
  14.5.2. Israel
  14.5.3. South Africa
  14.5.4. Rest of MEA
14.6. MEA Pen Needles Market - Opportunity Analysis Index, By Type, By Needle Length, By Therapy, By End-User, and Country, 2017 – 2023
14.7. MEA Pen Needles Market Dynamics – Trends

15. COMPETITION LANDSCAPE

15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Disease Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
  15.2.1. Novo Nordisk A/S (Denmark)
  15.2.2. Becton, Dickinson and Company (U.S.)
  15.2.3. B. Braun Melsungen AG (Germany)
  15.2.4. Ypsomed Holding AG (Switzerland)
  15.2.5. Terumo Corporation (Japan)
  15.2.6. HTL-STREFA S.A. (Poland)
  15.2.7. Artsana S.p.a (Italy)
  15.2.8. Allison Medical, Inc. (U.S.)
  15.2.9. UltiMed, Inc. (U.S.)
  15.2.10. ARKRAY Inc. (U.S)
  15.2.11. Owen Mumford Ltd. (U.K.)

16. RESEARCH METHODOLOGY

17. KEY ASSUMPTIONS AND ACRONYMS


More Publications